BACKGROUND: Troglitazone decreases insulin resistance and hyperglycemia in patients with non-insulin-dependent diabetes mellitus (NIDDM), but its effects on subjects without diabetes are not known. METHODS: We performed oral and intravenous glucose-tolerance tests, studies with the euglycemic-hyperi...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!